Drug profile · INN
tranylcypromine sulfate
TRANYLCYPROMINE SULFATE
tranylcypromine sulfate (TRANYLCYPROMINE SULFATE) is a monoamine oxidase inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — tranylcypromine sulfate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
tranylcypromine sulfate (TRANYLCYPROMINE SULFATE) is a monoamine oxidase inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Monoamine oxidase inhibitor
Primary target: Monoamine oxidase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is tranylcypromine sulfate?
tranylcypromine sulfate (TRANYLCYPROMINE SULFATE) is a monoamine oxidase inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for tranylcypromine sulfate?
TRANYLCYPROMINE SULFATE is a marketed brand name for tranylcypromine sulfate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of tranylcypromine sulfate?
tranylcypromine sulfate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.